From September 2024, a new vaccine for respiratory syncytial virus (RSV) will be available to older adults aged 75-79 years old, and to pregnant women (from 28 weeks) to protect their baby. Respiratory syncytial virus (RSV) is a common cause of coughs and colds. RSV infections usually get better by themselves, but can sometimes be … Continued